PRACTECAL-PKPD: Sub-study for TB-PRACTECAL Clinical Trial
Conditions: Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine Sponsors: Medecins Sans Frontieres, Netherlands; London School of Hygiene and Tropical Medicine; Global Alliance for TB Drug Development; University College, London; Drugs for Neglected Diseases; Swiss Tropical & Public Health Institute; eResearch Technology, Inc.; Ministry of Health, Republic of Uzbekistan; World Health Organization; Ministry of Health, Belarus; TB & HIV Investigative Network (THINK); Liverpool School of Tropical Medicine; Clinical HIV Reserach Unit, Wits Health Consortium; Hackensack University Medical Centre; University of California, San Francisco (UCSF), USA; London School of Hygiene and Tropical Medicine Clinical Reserach Department; University College London Institute for Global Health; University of Liverpool; Minsk Republican Research and Practical Centre for Pulmonology and Tuberculosis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avelox | Bedaquiline | Belarus Health | Clinical Trials | Linezolid | Moxifloxacin | Netherlands Health | Research | Study | Tropical Medicine | Tuberculosis | Uzbekistan Health | Zyvox